Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Oct
8
2012
FTC Releases Revised Green Guides Barnes & Thornburg LLP
Oct
5
2012
FTC Releases Final “Green Guides” for Environmental Marketing Claims Morgan, Lewis & Bockius LLP
Oct
5
2012
California Supreme Court Reaffirms “All Sums with Stacking” Rule on Long-Tail Injury Claims Neal, Gerber & Eisenberg LLP
Oct
4
2012
President’s Council of Advisors on Science and Technology Releases Report Faegre Drinker
Oct
3
2012
Plants Found in the Wild Are Not Patentable McDermott Will & Emery
Oct
3
2012
Prometheus Redux: Patentability of Isolated DNA Sequences Are Patentable Subject Matter McDermott Will & Emery
Oct
2
2012
Infrastructure for PEVs and EVs Varnum LLP
Sep
28
2012
GM to Improve Electric Vehicle Range Varnum LLP
Sep
27
2012
Another Hurdle for GHG Suits as Ninth Circuit Affirms District Court Ruling in Kivalina v. ExxonMobil ArentFox Schiff LLP
Sep
26
2012
Personalized Medicine Takes Off While Diagnostic Assays are Grounded
Sep
26
2012
Holland Batteries to Power Fleet Vehicles Varnum LLP
Sep
26
2012
Akami/McKesson Decision Re-defines Induced Infringement
Sep
24
2012
Appellate Court Ruling Permits Continued NIH Funding of Embryonic Stem Cell Research
Sep
22
2012
The Federal Circuit’s Recent “Safe Harbor” Ruling Could Impact Biosimilars Drug Development Faegre Drinker
Sep
21
2012
Are Biosimilars the Next Generation of Small Drug Manufacturers? Faegre Drinker
Sep
20
2012
More Electric Ford Automobiles Varnum LLP
Sep
20
2012
STEM Jobs Act May Be On the Horizon Greenberg Traurig, LLP
Sep
20
2012
A123 Announces Technology Advance Varnum LLP
Sep
17
2012
Energy and Environment Law Update - September 16, 2012 Mintz
Sep
16
2012
Johnson Controls Inc. to Dance with New Partners Varnum LLP
Sep
10
2012
Court of Appeals Expands Inducement for Patent Infringement Morgan, Lewis & Bockius LLP
Sep
7
2012
Federal Circuit Reaffirms the Patentability of Isolated DNA in Association for Molecular Pathology v. Myriad Sterne, Kessler, Goldstein & Fox P.L.L.C.
Sep
6
2012
Federal Circuit Resurrects ‘Induced Infringement;’ Narrows ‘Joint Infringement Defense’ Neal, Gerber & Eisenberg LLP
Sep
6
2012
Akamai/McKesson Decided– Implications for Personalized Medicine Patents Sterne, Kessler, Goldstein & Fox P.L.L.C.
Sep
1
2012
President Obama Issues Executive Order Promoting Increased Use of Combined Heat and Power Technology at Industrial Facilities Michael Best & Friedrich LLP
Aug
24
2012
Federal Circuit Breathes Life Back Into DNA Patents McDermott Will & Emery
Aug
23
2012
Biofuel Production Breakthrough at MSU Varnum LLP
Aug
22
2012
United States' First Offshore Wind Farm Obtains Critical Federal Approval McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins